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Clinical application of the Hybrid
Assistive Limb (HAL) for gait
training—a systematic review
Anneli Wall 1, 2*, Jörgen Borg1, 2 and Susanne Palmcrantz 1, 2
1 Department of Rehabilitation Medicine, Danderyd University Hospital, Stockholm, Sweden, 2 Department of Clinical
Sciences, Karolinska Institute, Stockholm, Sweden
Objective: The aim of this study was to review the literature on clinical applications of
the Hybrid Assistive Limb system for gait training.
Methods: A systematic literature search was conducted using Web of Science,
PubMed, CINAHL and clinicaltrials.gov and additional search was made using reference
lists in identified reports. Abstracts were screened, relevant articles were reviewed and
subject to quality assessment.
Results: Out of 37 studies, 7 studies fulfilled inclusion criteria. Six studies were single
group studies and 1 was an explorative randomized controlled trial. In total, these studies
involved 140 participants of whom 118 completed the interventions and 107 used HAL
for gait training. Five studies concerned gait training after stroke, 1 after spinal cord
injury (SCI) and 1 study after stroke, SCI or other diseases affecting walking ability. Minor
and transient side effects occurred but no serious adverse events were reported in the
studies. Beneficial effects on gait function variables and independence in walking were
observed.
Conclusions: The accumulated findings demonstrate that the HAL system is feasible
when used for gait training of patients with lower extremity paresis in a professional
setting. Beneficial effects on gait function and independence in walking were observed
but data do not allow conclusions. Further controlled studies are recommended.
Keywords: rehabilitation, robotics, gait, walking, locomotion, paresis, review, gait machine
Background
Normal gait depends on the functional integrity and interactions in sensory-motor neural net-
works at spinal and supraspinal levels (Bowden et al., 2013). This complex systemmay be disturbed
in many neurological conditions such as stroke or spinal cord injury (SCI) resulting in limited
mobility and impaired gait function, which are major challenges in neuro rehabilitation. Intensive,
repetitive task speciﬁc training may drive beneﬁcial neuroplasticity, enhance functional restitution
and improve ﬁnal outcome (Kwakkel et al., 2004; Langhorne et al., 2009, 2011; Peurala et al., 2014).
However, there is a need for further development of training methods in response to an increasing
understanding of the individual capacity for regaining functioning (Krakauer et al., 2012; Bowden
et al., 2013).
Approaches to improve gait function after stroke and SCI include treadmill training with
or without use of partial body weight support (BWS), yet the evidence to support this is
Wall et al. Hybrid Assistive Limb—a review
inconclusive (Schwartz and Meiner, 2013; Dobkin et al., 2014).
Gait machines (GM) may allow more reproducible gait move-
ments compared to conventional training and reduce the burden
on the therapist. GM work according to the end-eﬀector prin-
ciple (foot plates move the feet in a controlled gait pattern) or
as exoskeletons, which have joints matching the limb joints and
motors that drive movements over these joints to assist, e.g.,
leg movements (Hesse et al., 2010). A recent Cochrane review
concluded that electromechanically assisted gait training in com-
bination with physiotherapy after stroke increases the odds of
achieving independent walking and most so when applied for
severely impaired patients in the ﬁrst 3 months after stroke
(Mehrholz et al., 2013) but less clear after SCI (Mehrholz et al.,
2012).
The importance of incorporating more active participation
than allowed by gait machines to enhance training eﬀects and the
need for new concepts and devices are recognized (Dobkin, 2009;
Pennycott et al., 2012). One new approach is represented by the
Hybrid Assistive Limb system (HAL). HAL is an exoskeleton with
a hybrid system allowing both a voluntary and an autonomous
mode of action to support training of gait. HAL comprises a con-
trol algorithm and supporting devices, where each knee and hip
joint can be controlled separately. Key features of the HAL system
have been reported in detail (Kawamoto, 2002; Suzuki et al., 2007;
Kawamoto et al., 2010). Movements are triggered by use of either
the “Cybernic Voluntary Control” (CVC), which is based on the
users voluntary activation of gait muscles as recorded by sur-
face electromyography (EMG), or by the “Cybernic Autonomous
Control” (CAC), which is based on the users weight shifting and
input from force pressure sensors in the shoes. The CVC mode
allows the operator to adjust the degree of support for each joint
and reduce the support as training progress and to adjust settings
to achieve a gait pattern that is as close as possible to normal gait.
In case of complete loss of voluntary activation of gait muscles
the CAC mode may be used. Gait is then initiated and sustained
by input from force-pressure sensors in the shoes. HAL is man-
ufactured in single-leg and double-leg versions and training with
HAL may be performed with or without BWS.
A number of clinical studies with HAL have been conducted
and there is a need for an evaluation of available data to guide
further trials. The aim of this report was to provide a system-
atic review in order to evaluate current evidence with regard
to feasibility (i.e., usability and safety) and eﬀects and to make
recommendations for further studies.
Methods
A systematic search of the literature was conducted using the
databases Web of Science, PubMed, and CINAHL. Both MeSH
(Medical Subject Headings for Medline) terms and free text rel-
evant for the subject were used and detected synonyms were
added to the search. Search terms were (MeSH terms in bold):
((((robot OR robots OR robotic OR robotics OR robot-assisted
OR exoskeleton OR machine-assisted OR electro-mechanic OR
DGO OR “driven gait orthosis”))) AND (gait OR gaits OR walk-
ing OR walk OR walks OR locomotion OR “motor activity”))
AND (HAL OR “hybrid assistive limb” OR “wearable robot”).
Search limitations were “Humans” and “English,” while publica-
tion date was unlimited. Using the same search terms, a search
was also performed at clinicaltrials.gov, in order to identify ongo-
ing studies and/or unpublished papers (Clinicaltrials, online).
Abstracts identiﬁed were screened and studies were considered
relevant if they addressed any clinical application of the HAL sys-
tem regardless of study design. If needed the full text article was
retrieved and assessed. Relevant studies were exported to End-
Note where duplicates were identiﬁed and removed. Reference
lists of these studies were manually searched for further articles.
Studies were included if they were primary research articles, con-
cerned gait training with the Hybrid Assistive Limb. Studies only
reporting technology data, including only healthy subjects, sin-
gle subjects or reviews were excluded. Thirty-seven articles were
identiﬁed, 20 were retrieved in full text for assessment of eligibil-
ity and 13 of these did not fulﬁll inclusion criteria (see Figure 1).
Overall 7 studies met the inclusion criteria and were subject to
data extraction and analyses (Maeshima et al., 2011; Kawamoto
et al., 2013; Kubota et al., 2013; Ueba et al., 2013; Aach et al., 2014;
Nilsson et al., 2014; Watanabe et al., 2014). Included studies were
subject to critical review by two independent reviewers.
The quality of the included studies, regarding risk of con-
founding and bias, was evaluated in accordance with the Scot-
tish Intercollegiate Guidelines Network (SIGN) criteria (SIGN,
online1). According to SIGN the methodological quality can be
coded (++) meaning all or most of criteria fulfilled, (+) some of
the criteria fulfilled or (−) few or no criteria fulfilled. The evalu-
ation was performed independently by two investigators and in
case of disagreement, a third reviewer was consulted. Since two
investigators are authors of one of the included studies (Nilsson
et al., 2014) this study was assessed by a fourth investigator.
Data extraction was performed by one investigator and
checked by the two additional investigators. The extracted data
comprised; characteristics of participants, intervention protocols
and settings, outcome measures and eﬀects and feasibility.
Results
The 7 studies included 8–38 participants each, 6 were single
group studies and 1 was a randomized controlled trial (RCT). In
total, the studies involved 140 participants of whom 118 com-
pleted the intervention protocols and 107 used HAL for gait
training. Extracted study data and results of the quality evalua-
tion are presented in the Table 1. All included studies were found
to have a high risk of bias and confounding according to the SIGN
criteria and do not provide data for a meta-analysis.
Characteristics of Participants Included in the
Studies
The most frequent diagnosis reported was stroke (n = 106)
followed by complete or incomplete SCI (n = 16) and other
disorders (n = 18). Five of the studies included solely persons
with stroke, 1 study included solely persons with SCI (Aach et al.,
2014) and 1 study included persons with stroke (n = 12) and SCI
1SIGN. Scottish Intercollegiate Guidelines Network. Available online at: http://
www.sign.ac.uk/methodology/checklists.html [Accessed Dec 2014].
Frontiers in Systems Neuroscience | www.frontiersin.org 2 March 2015 | Volume 9 | Article 48
Wall et al. Hybrid Assistive Limb—a review
FIGURE 1 | Presentation of the results of the systematic search of the literature.
(n = 8) as well as other disorders (n = 18) (Kubota et al., 2013).
Mean age of the participants ranged from 48 to 67 years with a
total range of 18–90 years.
In 6 of the included studies a total of 65.7% (n = 67) of
the participants who completed the study intervention were men
and 34.3% (n = 35) were women. Ueba et al. (2013) did not
report gender for participants completing the study but among
the included 32% (n = 7) were men and 68% (n = 15) were
women.
The total time from disease onset to inclusion ranged from
6 days to 54 years. For persons with SCI the time from injury
ranged from 1 to 19 years and for persons with stroke this time
ranged from approximately 6 days to 16 years. Three studies
(Maeshima et al., 2011; Nilsson et al., 2014;Watanabe et al., 2014)
included persons early after stroke, with a mean range of 31–59
days since stroke onset. Two other studies included persons later
than 1 year and up to 16 years after stroke onset (Kawamoto et al.,
2013; Kubota et al., 2013).
The number of reported dropouts during the study interven-
tions ranged from 6 to 10 and was 22, in total (18 with stroke,
1 with SCI and 3 participants with other diagnosis,). Reported
reasons for dropouts were medical (n = 5), technical (n = 1),
discharge (n = 2), personal (n = 4) and withdrawal of consent
(n = 4). Another 6 participants dropped out due to inappropriate
size of shoes, lumbar spondylosis which prevented correct ﬁtting
and/or depressive status.
Intervention Protocols and Settings
All except 1 (Ueba et al., 2013) of the 7 studies speciﬁcally
addressed gait training. The HAL training protocols showed a
great variation with regard to frequency, intensity and number of
sessions performed. Most studies applied HAL training≥2 times
per week during ≥4 weeks with durations of ≥20min per ses-
sion. In the studies involving persons with stroke, the total num-
ber of sessions per participant training with HAL ranged from 1
(Maeshima et al., 2011) to 31 (Nilsson et al., 2014). In studies
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involving persons with SCI, Aach et al. (2014) used a mean of
51.75 sessions while the number of sessions for persons with SCI
in the study by Kubota et al. (2013) was 16. Data on the use of the
active CVC mode and the autonomous CAC mode was not con-
sistently reported. Based on the information provided, we antici-
pate that 6 of the studies used the CVC mode during training but
the extent is not clear. One study (Ueba et al., 2013) did not report
on modes used. Four studies reported the total length of each
training sessions to be approximately 90min including assess-
ments, donning, doﬃng and eﬀective walking time. The eﬀective
training time in these studies was approximately 20–30min per
session. Training with HAL was performed by use of BWS and/or
a mobile suspension system in 5 studies, by over ground train-
ing in 1 study and was not deﬁned in 1 study. Four studies were
conducted in inpatient rehabilitation settings and 3 in out-patient
care (see Table 1).
Outcome Measures and Effects
All assessments were performed without wearing HAL except for
one study (Maeshima et al., 2011) where measurements were per-
formed both with and without HAL. Outcome measures mainly
related to walking ability. Most frequently used were the 10m
walking test (n = 6) (Wade et al., 1987), Timed up and Go
(n = 5) (Podsiadlo and Richardson, 1991), and Berg Balance
Scale (n = 3) (Berg et al., 1992). Assessments performed at base-
line and after the training period were reported in all studies
except 1 (Ueba et al., 2013). No study reported on a long-term
follow up. The explorative RCT (Watanabe et al., 2014) com-
pared the eﬀect of HAL-training to the eﬀect of conventional
training in the subacute phase after stroke and included 11 par-
ticipants in each group. The study shows a signiﬁcant diﬀerences
(p = 0.04) according to the Functional Ambulation Categories
(FAC) (Holden et al., 1984) between groups, in favor for the HAL
training group. This study has several limitations with regard to
study sample size, varying time after stroke and lack of blind-
ing of outcome assessments, as recognized by the authors. One
other study (Nilsson et al., 2014) also used FAC and observed
improvements suggesting a beneﬁcial eﬀect in a single group.
Other studies also report on varying eﬀects such as improve-
ments in walking- and torso posture, gait speed, number of steps
and cadence, functional ambulation/independent walking, motor
function in lower extremity, activity performance and/or balance
(see Table 1).
Adverse Events
All studies except 1 (Maeshima et al., 2011) explicitly reported
on adverse events. Except for transient complaints related to
pressure of the suit, irritated skin, training related pain etc., no
adverse events during training with HAL were reported.
Discussion
The aim of this review was to explore existing evidence regard-
ing gait training with the exoskeleton HAL (Hybrid Assistive
Limb). We included 7 studies, each with small study samples but
comprising a total of 140 patients. Of these, 118 completed the
intervention and 107 used HAL. Studies diﬀered in terms of aim,
design, duration of intervention, patients/diagnosis, setting and
participant characteristics as well as allocation, randomization,
blinding and outcome measures. Only 1 study compared train-
ing with HAL with other training (Watanabe et al., 2014) but
outcome assessment in that study was not blinded. Although no
study provides conclusive data on the eﬀects of gait training with
HAL as compared to other training and the risk of confounding
and bias was considered high, the experiences of training with
HAL and the responses that were observed will be useful in the
design of further studies.
Feasibility
In total, adult subjects within a broad age range (18–90 years)
participated. Both genders were represented, however two thirds
were men. Since the majority of subjects had a stroke diagno-
sis and gender proportions are fairly similar in this diagnostic
group, the uneven distribution is surprising but only scarcely
commented on in the studies.
Study participants in both post-acute and long-term after
stroke onset were represented and 88 out of 106 included subjects
completed the study interventions. One small experimental study
included subjects with paraplegia 1–19 years after spinal cord
injury where all completed the intervention (Aach et al., 2014)
while no study addressed eﬀects of training with HAL in the post-
acute phase after SCI. The severity of paresis and gait problems
varied both within and between the included studies, from severe
(only able to maintain sitting balance) to moderate (independent
walkers) and a corresponding use of HAL mode and BWS. Rea-
sons for training of independent walkers were not stated or dis-
cussed in the included studies although plausible beneﬁcial eﬀects
may be, e.g., an increase in walking speed and/or distance or level
of independence. The reported numbers of dropouts were low
and a total of 107 participants, representing a broad spectrum of
motor impairments completed >1500 training sessions with the
HAL system without any reported serious adverse events.
Thus, the accumulated results of the included studies demon-
strate that training with the HAL system is feasible when applied
in professional settings, irrespective of the patients age and sex
and the severity of the lower extremity paresis. The feasibility of
training with HAL in the post-acute phase after SCI will need to
be explored further.
Intervention Protocols and Settings
Even though not stated, the variability in applied frequency,
intensity and duration of the reported training sessions and eval-
uations of outcome, probably reﬂect both theoretical and practi-
cal considerations of, e.g., training needed to achieve signiﬁcant
eﬀects, participants’ functional level and study resources. Reason-
ably, the optimal design would allow training programs to be on
the edge for each participant’s capacity with regard to the inten-
sity and length of each training session. The intensity and length
of the training periods must also consider the patient’s functional
level as well as the capacity and aims with regard to, e.g., on neu-
roplasticity, musculoskeletal function, cardiovascular function,
gait pattern or independence in walking. Three or more sessions
weekly during the training period would probably be justiﬁed
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from a neuroplasticity and relearning perspective (Bowden et al.,
2013).
Both single- and double-leg versions of HAL were used even
though not speciﬁed in all studies. Reasonably the double-leg
version is most relevant for subjects with paraparesis and the
single-leg version most often appropriate for subjects with one
sided paresis.
Only 2 of the studies included patients early after stroke
when the potential to utilize beneﬁcial neuroplasticity processes
is higher (Bowden et al., 2013) and there is a need for controlled
HAL studies in this area. Post-acute studies are more challenging
as they have to consider both the impact of spontaneous recovery
early after the event as well as other post-acute health problems.
Outcome Measures and Effects
Outcome measures in the included studies primarily relate to
aspects of gait function and walking. Most frequently used was
the 10m walking test, which is a measure of over ground walking
speed. Six studies report a positive impact on gait function after
HAL training, 5 of these speciﬁcally on walking speed and 2 stud-
ies report increased level of independence in walking according
to the FAC (Nilsson et al., 2014; Watanabe et al., 2014). FAC is
the most commonly used outcome measure in studies of walking
after robotic training for patients with severe to moderate walk-
ing limitations in both the acute and chronic phase after stroke
(Geroin et al., 2013). FAC takes the persons level of indepen-
dence and amount of personal assistance required into account,
which from the individuals’ perspective is more important than
walking speed. However, gait speed may be associated with func-
tional ambulation ability (Perry et al., 1995; Dobkin et al., 2014)
and a gait speed improvement may generate improved function
and quality of life (Schmid et al., 2007). Therefore, we suggest
both the FAC and the 10m walking test to be used in further
studies. In studies including participants with severely impaired
gait function at baseline and who are unable to walk 10m, the
2min walk test (Kosak and Smith, 2005) is an option to be con-
sidered in order to achieve baseline data also when participants
cannot walk (i.e., 0m in 2min). The potential eﬀect of HAL train-
ing on movement related function such as gait pattern is poorly
addressed in the included studies. Future studies should consider
using assessments that cover also these aspects, for example by
use of 3-dimensional motion analysis.
Data on self-perceived aspects of the training were scarce and
we found no data on perceived activity performance, participa-
tion in everyday life, health or cost-eﬀectiveness that need to
be approached in future studies. Further, no study reported on
potential eﬀects on cardiovascular, metabolic, emotional or cog-
nitive functions of training with the HAL system. The possible
additional value of training with HAL in these areas should be of
interest in future studies.
Further, controlled studies should compare training with the
HAL system with the most relevant alternative training method.
As pointed out, gait machines such as the Lokomat diﬀers from
the HAL system in terms of the degree of active patient par-
ticipation. Comparison studies of these gait machines would be
of interest. However, until now, studies using Lokomat have
not consistently demonstrated eﬀects, regarding sensory-motor
function, gait speed, balance and/or mobility, that are superior to
those achieved with conventional training (Swinnen et al., 2010;
Ucar et al., 2014; van Nunen et al., 2014) although there might
be other advantages such as less therapist burden. Thus, further
studies that compare the eﬀects of training with the HAL sys-
tem to the eﬀects of well designed “conventional training” are
justiﬁed. Moreover, studies combining robotics with other ther-
apeutic interventions with increasing evidence support, such as
Fluoxetine (Chollet et al., 2011), BMI (Brain-Machine Interface)
(Shindo et al., 2011; Noda et al., 2012) or brain stimulation (Liew
et al., 2014) are also of great interest.
Currently, there are a number of exoskeletons at various stages
of development or clinical applications. In addition to diﬀerences
in mechanical design and control strategies existing exoskeletons
uses diﬀerent activation systems to produce movement of the
limb. The most common are hydraulic, pneumatic, and electric
motor actuator. In a recent review by Chen et al. (2013) focused
on lower extremity robots, the authors divides exoskeletons in
diﬀerent subgroups depending on their functioning and design
and conclude that real-time control strategies with timely assis-
tance are a new promising area in rehabilitation therapy. The
importance of incorporating more active participation in elec-
tromechanical gait training (Dobkin, 2009; Pennycott et al., 2012)
as well as of allowing variation of the task during training to pro-
mote adequate motor learning (Hidler and Sainburg, 2011) has
also been addressed previously.
Some recently developed designs of exoskeletons have taken
this into account by establishing intention-based control strate-
gies. In the Ekso (Ekso Bionics, online2), ReWalk (Rewalk,
online3), and in Indego (Indego, online4) stepping is initiated
by shifting of bodyweight. In Indego, shifting of body weight is
used in combination with functional electric stimulation (FES).
Another exoskeleton the MINDWALKER (Mindwalker, online5)
uses EEG and EMG based control.
Recent studies using Ekso for patients in diﬀerent stages after
SCI conclude that the system is safe and show improvements in
walking while wearing Ekso (Ekso Clinical Research, online6).
For inpatient rehabilitation after stroke the authors ﬁnd Ekso
safe to use and indicate that the training may have an eﬀect on
cadence as a result of training with Ekso (Ekso Clinical Research,
online). However, the number of participant in these studies are
limited and do not allow any further conclusions. Ongoing stud-
ies after both SCI and severe stroke (Clinicaltrials, online) will
evaluate potential eﬀects on ambulation and mobility.
Indego has been introduces in single-subject clinical trials in
SCI patients (Quintero et al., 2011; Farris et al., 2014). An ongo-
ing study will evaluate the safety and eﬀectiveness of using Indego
2Ekso Bionics. Available online at: http://intl.eksobionics.com/ekso. [Accessed
March 2015].
3ReWalk. Available online at: http://www.rewalk.com/products/rewalk-rehabili
tation/. [Accessed March 2015].
4Indego. Available online at: http://www.indego.com/indego/en/home. [Accessed
March 2015].
5Mindwalker. Available online at: https://mindwalker-project.eu/. [Accessed
March 2015].
6Ekso Clinical Research, Summary of Findings. Available online at: http://intl.
eksobionics.com/clinical-research-summary-download. [Accessed March 2015].
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for non-ambulatory or poorly ambulatory SCI patients during
standing and walking (Clinicaltrials, online7).
In a study by Zeilig et al. (2012) ReWalk was found
to be well tolerated and did not cause any adverse events
among persons with SCI. This was repeated in a study by
Spungen et al. (ReWalk Peer Reviewed Publications, online8)
where persons with motor-complete paraplegia performed dif-
ferent community-based activities while wearing ReWalk. Several
ongoing studies where ReWalk is used after SCI are registered at
Clinicaltrials.gov.
Like the HAL, exoskeletons such as the powered knee-ankle-
foot-orthosis (KAFO) (Sawicki and Ferris, 2009) and NEU-
ROExos (Cain et al., 2007) use EMG activity to detect a
person’s intended movement. In both KAFO and NEUROExos
EMG activity is used to control the activation of a pneumatic
power system to provide torque over the ankle and/or knee
joint. In HAL the wearer’s joint torque is estimated from the
EMG signals on both hip and knee muscles and an electri-
cal motor actuator is used to generate power over these joints
(Suzuki et al., 2007).
7Clinicaltrials.gov. Available online at: https://www.clinicaltrials.gov/ [Accessed
Dec 2014].
8ReWalk, Peer Reviewed Publications. Available online at: http://www.rewalk.
com/technology/peer-reviewed-publications-copy/. [Accessed March 2015].
This brief survey of other exoskeletons points to a general need
for randomized controlled studies where exoskeletons that allow
active participation are compared to other types of interventions
as well as for studies with larger study populations.
Study Limitations
Since the Hybrid Assistive Limb was developed and is most
frequently used in Japan there might be studies published in
Japanese journals that were not included in this review. Of note,
in 6 of the included studies, the inventor and CEO of the com-
pany, Professor Y. Sankai, behind the Hybrid Assistive Limb sys-
tem is one co-author. No studies using qualitative approach were
discovered, which could have been due to the search strategy
used. However, even when a broader search was performed, no
qualitative studies appeared.
Conclusions and Recommendations
This review identiﬁed consistent evidence that the use of the HAL
system is feasible when used for gait training in hospital and
rehabilitation settings. Data suggest that such training may have
beneﬁcial eﬀects on gait function and independence in walking
after stroke and after spinal cord injury, but do not allow any con-
clusions in this respect. Further, well designed controlled studies
in these areas are recommended to explore eﬀect sizes and to be
followed by larger, conﬁrmatory studies.
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